200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 201349-37-3

201349-37-3

201349-37-3 | Pyridinium, 1-methyl-4-[[(phenylmethyl)amino]carbonyl]-, iodide (1:1)

CAS No: 201349-37-3 Catalog No: AG002DD3 MDL No:

Product Description

Catalog Number:
AG002DD3
Chemical Name:
Pyridinium, 1-methyl-4-[[(phenylmethyl)amino]carbonyl]-, iodide (1:1)
CAS Number:
201349-37-3
Molecular Formula:
C14H15IN2O
Molecular Weight:
354.1862
IUPAC Name:
N-benzyl-1-methylpyridin-1-ium-4-carboxamide;iodide
InChI:
InChI=1S/C14H14N2O.HI/c1-16-9-7-13(8-10-16)14(17)15-11-12-5-3-2-4-6-12;/h2-10H,11H2,1H3;1H
InChI Key:
ILSOAHPXYZRFBA-UHFFFAOYSA-N
SMILES:
C[n+]1ccc(cc1)C(=O)NCc1ccccc1.[I-]
UNII:
G22FG6Q00B

Properties

Complexity:
241  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
354.023g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
354.191g/mol
Monoisotopic Mass:
354.023g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
33A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
[Influence of chemically different antiviral substances on the expression of IFNα, PKR, OAS1a and RNAse L genes]. Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20120101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
[Calcium, cholecalciferol, and amizon: essential components in the complex therapy of chronic hepatitis]. Likars'ka sprava 20040101
[Comparative results of therapy with amizon and reaferon of patients with chronic viral hepatitis B and C and kidney complications]. Likars'ka sprava 20030101
[Experience gained with the drug amizon in the treatment of patients with mumps, with special reference to its effects on some biochemical markers]. Likars'ka sprava 20010101
[Efficacy of amizon in the treatment of chronic toxic hepatitis and its immunocorrective action]. Likars'ka sprava 20010101
[Using amyzon in the treatment of patients with sore throat]. Likars'ka sprava 20010101
[The results of a clinical trial of the new drug agent carbabenzpyride]. Likars'ka sprava 19920101

Related Products

© 2019 Angene International Limited. All rights Reserved.